These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6453154)

  • 21. Autoreactive cells in cancer-active immunotherapy: their cytotoxic potential and genetic restriction.
    Olsson L; Kiger N; Mathe G
    Transplant Proc; 1980 Mar; 12(1):167-71. PubMed ID: 7368287
    [No Abstract]   [Full Text] [Related]  

  • 22. Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia.
    Schmidt W; Festenstein H; Atfield G
    Transplant Proc; 1980 Mar; 12(1):29-31. PubMed ID: 7368291
    [No Abstract]   [Full Text] [Related]  

  • 23. Tolerance induction by fusion of fetal thymus lobes in organ culture.
    DeLuca D; Mandel TE; Luckenbach GA; Kennedy MM
    J Immunol; 1980 Apr; 124(4):1821-9. PubMed ID: 6444965
    [No Abstract]   [Full Text] [Related]  

  • 24. Helper cells in the autologous mixed lymphocyte reaction. II. Age-related helper defect for generation of TNP-self cytotoxic cells in NZB mice.
    Wolos JA; Smith JB
    J Immunol; 1982 Jan; 128(1):269-75. PubMed ID: 6459369
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of tumor cell extracts in immunotherapy of murine EL-4 leukemia.
    Cantrell JL; McLaughlin CA; Ribi E
    Cancer Res; 1979 Apr; 39(4):1159-67. PubMed ID: 421199
    [No Abstract]   [Full Text] [Related]  

  • 26. Alloreactive cytotoxic anti-H-2 antibodies in sera of the syngeneically immunized C57BL/10ScSnPh, BALB/cJPh, and B10.A/SnPh mice.
    Capková J; Hasek M; Kousalová M; Holán V; Boubelík M
    Folia Biol (Praha); 1983; 29(2):200-8. PubMed ID: 6862049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.
    Stukart MJ; Vos A; Boes J; Melvold RW; Bailey DW; Melief CJ
    J Immunol; 1982 Mar; 128(3):1360-4. PubMed ID: 6799575
    [No Abstract]   [Full Text] [Related]  

  • 28. Models for syngeneic adoptive chemoimmunotherapy of murine leukemias.
    Fefer A; Einstein AB; Cheever MA; Berenson JR
    Ann N Y Acad Sci; 1976; 276():573-83. PubMed ID: 1088388
    [No Abstract]   [Full Text] [Related]  

  • 29. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL; Bortin MM; Rimm AA
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of a new interferon inducer and leukocyte interferon for a significant enhancement of the immunocytotherapy of leukemia in mice].
    Madzhidov AV; Poverennyĭ AM; Popov GA; Fuks BB
    Biull Eksp Biol Med; 1983 Jan; 95(1):63-5. PubMed ID: 6830962
    [No Abstract]   [Full Text] [Related]  

  • 31. Foreign H-2-like alloantigens of syngeneic tumor cells can act as new "restriction" molecules for the associative recognition of non-H-2 or tumor-associated antigens by lymphoid effectors in the cytostasis assay.
    Festenstein H; de Giorgi L; Matossian-Rogers A
    Transplant Proc; 1981 Dec; 13(4):1877-9. PubMed ID: 7330973
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection against graft-versus-host disease by large doses of donor CD4+ T cells: a novel approach to bone marrow transplantation.
    Heath WR; Miller JF; Sprent J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1222-4. PubMed ID: 8442095
    [No Abstract]   [Full Text] [Related]  

  • 33. Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies.
    Rosenstein M; Rosenberg SA
    J Natl Cancer Inst; 1984 May; 72(5):1161-5. PubMed ID: 6609266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of immunity to murine leukemia (LSTRA) by Bacillus Calmette-Guérin.
    Bartlett GL; Kreider JW; Purnell DM
    Cancer Res; 1978 Dec; 38(12):4401-8. PubMed ID: 719627
    [No Abstract]   [Full Text] [Related]  

  • 35. Helper cells in the autologous mixed lymphocyte reaction. I. Generation of cytotoxic T cells recognizing modified self H-2.
    Wolos JA; Smith JB
    J Immunol; 1981 Aug; 127(2):711-5. PubMed ID: 6454726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vivo distribution of transferred syngeneic, allogeneic, and xenogeneic lymphoid cells: implication for the adoptive immunotherapy of tumors.
    Mathisen DJ; Rosenberg SA
    J Immunol; 1980 May; 124(5):2295-300. PubMed ID: 7365258
    [No Abstract]   [Full Text] [Related]  

  • 37. Activation of allosensitized memory lymphocytes into secondary cytotoxic T lymphocytes by third-party stimulator cells: genetic mapping of the stimulating antigens.
    Fan J; Bonavida B
    Transplant Proc; 1981 Dec; 13(4):1897-900. PubMed ID: 7330974
    [No Abstract]   [Full Text] [Related]  

  • 38. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens.
    Imamura M; Martin WJ
    J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147
    [No Abstract]   [Full Text] [Related]  

  • 39. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.